Ayala Pharmaceuticals, Inc.
Ayala Pharmaceuticals, Inc. (ADXS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ADXS · as of Jun 15, 2026
Key Statistics
Explore Ayala Pharmaceuticals, Inc. Data
adxs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 75.0%
Competitors & Peers
adxs competitorsADXS
AAGH
AGNPF
AGTX
APLIF
HESGStock Performance
Full HistoryAbout Ayala Pharmaceuticals, Inc.
Ayala Pharmaceuticals, Inc. a clinical-stage oncology firm, focuses on developing and commercializing small molecule therapies for individuals battling rare tumors and aggressive cancers. Its primary…
what is ayala pharmaceuticals, inc. · adxs stock overview · ayala pharmaceuticals, inc. company profile · who is ayala pharmaceuticals, inc. ceo · adxs OTC · ayala pharmaceuticals, inc. headquarters · ayala pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Ayala Pharmaceuticals, Inc. (ADXS) is a Healthcare company in the Biotechnology industry, listed on OTC since May 8, 2020. As of the latest trading session, ADXS stock price is $0.60, with a market capitalization of $25.7M. The stock has returned +1911.83% over the past 12 months and +663.02% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Ayala Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Ayala Pharmaceuticals, Inc. reported revenue of $13000.00 and net income of -$48.1M. For detailed data — including Ayala Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ayala Pharmaceuticals, Inc. (ADXS) stock price is $0.60. The stock is traded on OTC under the ticker symbol ADXS. The 52-week range is $0.00 – $0.80.